thalidomide has been researched along with Benign Chronic Pemphigus in 8 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 6 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoto, A | 1 |
| Makino, T | 1 |
| Mizawa, M | 1 |
| Matsui, Y | 1 |
| Takemoto, K | 1 |
| Furukawa, F | 1 |
| Kataoka, K | 1 |
| Nakano, H | 1 |
| Sawamura, D | 1 |
| Shimizu, T | 1 |
| Antoñanzas, J | 1 |
| Tomás-Velázquez, A | 1 |
| Rodríguez-Garijo, N | 1 |
| Estenaga, Á | 1 |
| Salido-Vallejo, R | 1 |
| Di Altobrando, A | 1 |
| Sacchelli, L | 1 |
| Patrizi, A | 1 |
| Bardazzi, F | 1 |
| Siliquini, N | 1 |
| Deboli, T | 1 |
| Marchetti Cautela, J | 1 |
| Mangia, A | 1 |
| Fraccalvieri, M | 1 |
| Dapavo, P | 1 |
| Quaglino, P | 1 |
| Ribero, S | 1 |
| Riquelme-Mc Loughlin, C | 1 |
| Iranzo, P | 1 |
| Mascaró, JM | 1 |
| Kearney, N | 1 |
| Raichura, S | 1 |
| Houghton, J | 1 |
| O'Kane, D | 1 |
| Kieffer, J | 1 |
| Le Duff, F | 1 |
| Montaudié, H | 1 |
| Chiaverini, C | 1 |
| Lacour, JP | 1 |
| Passeron, T | 1 |
| Dadban, A | 1 |
| Guillot, B | 1 |
1 review available for thalidomide and Benign Chronic Pemphigus
| Article | Year |
|---|---|
Two cases of Hailey-Hailey disease effectively treated with apremilast and a review of reported cases.
Topics: Adult; Calcium-Transporting ATPases; Female; Humans; Male; Mutation; Pemphigus, Benign Familial; Tha | 2021 |
7 other studies available for thalidomide and Benign Chronic Pemphigus
| Article | Year |
|---|---|
Apremilast in combination with botulinum toxin-A injection for recalcitrant Hailey-Hailey disease.
Topics: Botulinum Toxins, Type A; Humans; Pemphigus, Benign Familial; Thalidomide | 2022 |
Successful treatment of refractory Hailey-Hailey disease with apremilast.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Pemphigus, Beni | 2020 |
Combination of dermabrasion and Apremilast for Hailey-Hailey disease.
Topics: Dermabrasion; Humans; Pemphigus, Benign Familial; Thalidomide | 2021 |
Apremilast in benign chronic pemphigus (Hailey-Hailey disease).
Topics: Adult; Chronic Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pemphigus, Benign Fami | 2020 |
Old drug, new tricks - successful treatment of Hailey-Hailey disease with thalidomide.
Topics: Administration, Oral; Female; Humans; Keratolytic Agents; Middle Aged; Pemphigus, Benign Familial; T | 2021 |
Treatment of Severe Hailey-Hailey Disease With Apremilast.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Dose-Response Relationship, D | 2018 |
Oesophageal involvement in familial benign chronic pemphigus.
Topics: Administration, Oral; Diagnosis, Differential; Esophageal Diseases; Esophagoscopy; Female; Humans; M | 2006 |